Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03206723Phase 2Unknown
Phase 2, randomised, open-label trial in corneal abrasion (2 arms), sponsored by The Lundquist Institute. Primary endpoint: Pain scale at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03206723.